Related Experiment Video
Updated: Jul 10, 2026
06:28
E-Patient Counseling Trial (E-PACO): Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
Randomized clinical trial design for assessing noninferiority when superiority is expected
Boris Freidlin1, Edward L Korn, Stephen L George
1Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD 20892, USA. freidlinb@ctep.nci.nih.gov
Summary
This study introduces a novel hybrid trial design for evaluating new therapies. This approach significantly reduces sample size requirements for noninferiority trials while allowing for superiority testing.
Area of Science:
- Clinical Trials Methodology
- Biostatistics
- Pharmacoeconomics
Background:
- Randomized clinical trials (RCTs) are crucial for evaluating new therapies.
- Noninferiority trials assess if a new therapy is not unacceptably worse than standard care.
- Traditional noninferiority trials often necessitate large sample sizes.
Purpose of the Study:
- To present a hybrid trial design for evaluating new therapies.
- To demonstrate a method for reducing sample size in noninferiority trials.
- To incorporate superiority testing within a noninferiority framework.
Main Methods:
- Description of a novel hybrid clinical trial design.
- Methodology for sample size reduction compared to standard noninferiority designs.
- Integration of formal superiority and noninferiority tests.
Main Results:
- The proposed hybrid design requires a dramatically smaller sample size.
- This design efficiently evaluates therapies with potential efficacy improvements and favorable toxicity profiles.
- The hybrid approach allows for simultaneous assessment of superiority and noninferiority.
Conclusions:
- A hybrid trial design offers a more efficient alternative for specific noninferiority trial settings.
- This approach can lead to substantial reductions in sample size and resource allocation.
- The design facilitates a comprehensive evaluation of new therapeutic interventions.
Related Concept Videos
01:20Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs
Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to subjects...
01:15Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
01:13Randomized Experiments
The randomization process involves assigning study participants randomly to experimental or control groups based on their probability of being equally assigned. Randomization is meant to eliminate selection bias and balance known and unknown confounding factors so that the control group is similar to the treatment group as much as possible. A computer program and a random number generator can be used to assign participants to groups in a way that minimizes bias.
Simple randomization
Simple...
Simple randomization
Simple...
01:16Crossover Experiments
Crossover experiments, also called the repeated-measurements design, is a study design in which all experimental units are exposed to all treatments in different periods. Crossover experiments are generally used in psychology, the pharmaceutical industry, agriculture, and medicine.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
Crossover designs are performed even with smaller sample sizes since the samples can act as their controls. These are better than simple randomized trials since patients are exposed to all the treatments.
01:11Blinding
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...